XML 30 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flow from operating activities:    
Net loss $ (597)  
Cash flow from financing activities:    
Partnership distributions (7,675)  
Cash and cash equivalents, end of period 1  
QualityTech, LP [Member]
   
Cash flow from operating activities:    
Net loss (597) (8,159)
Adjustments to reconcile net loss to net cash provided by operating activities    
Depreciation and amortization 32,701 24,351
Amortization of deferred loan costs 2,193 2,582
Equity-based compensation expense 1,305 303
Write off of deferred loan costs relating to retired debt 2,031 1,434
Restructuring charge   3,291
(Gain) loss on sale/disposal of property   (948)
Changes in operating assets and liabilities    
Rents and other receivables, net (587) 1,179
Accrued interest on member advances   1,726
Prepaid expenses (1,510) (719)
Restricted cash 146 1,013
Other assets 291 134
Accounts payable and accrued liabilities (4,888) 1,126
Advance rents, security deposits and other liabilities 244 (1,447)
Deferred income 816 1,106
Net cash provided by operating activities 32,145 26,972
Cash flow from investing activities:    
Proceeds from sale of property   1,549
Acquisition of real estate (21,174)  
Additions to property and equipment (102,924) (86,351)
Net cash used in investing activities (124,098) (84,802)
Cash flow from financing activities:    
Credit facility proceeds 563,500 375,000
Debt repayment (456,994) (366,308)
Payment of swap liability   (4,377)
Payment of deferred financing costs (4,483) (4,591)
Partnership distributions (7,633)  
Repurchase of equity awards (13)  
Principal payments on capital lease obligation (496) (237)
Scheduled mortgage principal debt repayments (1,880) (2,390)
Equity issuance costs (1,776)  
Equity proceeds, net of costs   60,000
Net cash provided by financing activities 90,225 57,097
Net decrease in cash and cash equivalents (1,728) (733)
Cash and cash equivalents, beginning of period 8,232 7,342
Cash and cash equivalents, end of period 6,504 6,609
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION    
Cash paid for interest (excluding deferred financing costs) 14,265 16,617
Noncash investing and financing activities:    
Accrued capital additions 20,939 26,456
Accrued deferred financing costs 990  
Accrued equity issuance costs 447  
Member advances exchanged for LP units $ 10,000